{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:08:50Z","timestamp":1762542530308},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5,20]]},"DOI":"10.4103\/0366-6999.181965","type":"journal-article","created":{"date-parts":[[2016,5,6]],"date-time":"2016-05-06T10:21:18Z","timestamp":1462530078000},"page":"1140-1146","source":"Crossref","is-referenced-by-count":6,"title":["Aberrant Alternative Polyadenylation is Responsible for Survivin Up-regulation in Ovarian Cancer"],"prefix":"10.1097","volume":"129","author":[{"given":"Xiang-Jun","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Ping","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Hong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-2-20210129","doi-asserted-by":"crossref","first-page":"995","DOI":"10.3892\/ijo.2013.2047","article-title":"A dynamic interplay between alternative polyadenylation and microRNA regulation: Implications for cancer (Review)","volume":"43","author":"An","year":"2013","journal-title":"Int J Oncol"},{"key":"R2-2-20210129","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1101\/gr.132563.111","article-title":"A quantitative atlas of polyadenylation in five mammals","volume":"22","author":"Derti","year":"2012","journal-title":"Genome Res"},{"key":"R3-2-20210129","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1101\/gr.115295.110","article-title":"Differential genome-wide profiling of tandem 3' UTRs among human breast cancer and normal cells by high-throughput sequencing","volume":"21","author":"Fu","year":"2011","journal-title":"Genome Res"},{"key":"R4-2-20210129","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1158\/1078-0432.CCR-12-0543","article-title":"Alternative cleavage and polyadenylation during colorectal cancer development","volume":"18","author":"Morris","year":"2012","journal-title":"Clin Cancer Res"},{"key":"R5-2-20210129","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1093\/hmg\/ddv089","article-title":"Genome-wide profiling of polyadenylation sites reveals a link between selective polyadenylation and cancer metastasis","volume":"24","author":"Lai","year":"2015","journal-title":"Hum Mol Genet"},{"key":"R6-2-20210129","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.cell.2009.06.016","article-title":"Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells","volume":"138","author":"Mayr","year":"2009","journal-title":"Cell"},{"key":"R7-2-20210129","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/1756-0500-5-164","article-title":"Identifying microRNA\/mRNA dysregulations in ovarian cancer","volume":"5","author":"Miles","year":"2012","journal-title":"BMC Res Notes"},{"key":"R8-2-20210129","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1093\/nar\/gkt525","article-title":"Integrated analysis of microRNA and mRNA expression: Adding biological significance to microRNA target predictions","volume":"41","author":"van Iterson","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"R9-2-20210129","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3760\/cma.j.issn.0366-6999.20130843","article-title":"Shortening of the 3' untranslated region: An important mechanism leading to overexpression of HMGA2 in serous ovarian cancer","volume":"127","author":"He","year":"2014","journal-title":"Chin Med J"},{"key":"R10-2-20210129","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s10735-014-9591-2","article-title":"The expression of HER-2\/neu (c-erbB2), survivin and cycline D1 in serous ovarian neoplasms: Their correlation with clinicopathological variables","volume":"45","author":"Turan","year":"2014","journal-title":"J Mol Histol"},{"key":"R11-2-20210129","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.4161\/cc.8.17.9457","article-title":"Survivin as a global target of intrinsic tumor suppression networks","volume":"8","author":"Guha","year":"2009","journal-title":"Cell Cycle"},{"key":"R12-2-20210129","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.canlet.2012.03.005","article-title":"Targeting survivin in cancer","volume":"332","author":"Altieri","year":"2013","journal-title":"Cancer Lett"},{"key":"R13-2-20210129","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.3390\/ijms15022494","article-title":"Survivin as a preferential target for cancer therapy","volume":"15","author":"Mobahat","year":"2014","journal-title":"Int J Mol Sci"},{"key":"R14-2-20210129","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11033-013-2856-0","article-title":"Transcriptional regulation of the survivin gene","volume":"41","author":"Boidot","year":"2014","journal-title":"Mol Biol Rep"},{"key":"R15-2-20210129","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1701-2163(15)30659-9","article-title":"The fallopian tube as the origin of high grade serous ovarian cancer: Review of a paradigm shift","volume":"36","author":"Reade","year":"2014","journal-title":"J Obstet Gynaecol Can"},{"key":"R16-2-20210129","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","article-title":"Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca; Tp53;Pten models","volume":"24","author":"Perets","year":"2013","journal-title":"Cancer Cell"},{"key":"R17-2-20210129","first-page":"691","article-title":"Increasing specificity of real time PCR to detect microRNA through primer design and annealing temperature increase (in Chinese)","volume":"41","author":"He","year":"2009","journal-title":"Beijing Da Xue Xue Bao"},{"key":"R18-2-20210129","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1158\/0008-5472.CAN-04-0496","article-title":"Normalization of real-time quantitative reverse transcription-PCR data: A model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets","volume":"64","author":"Andersen","year":"2004","journal-title":"Cancer Res"},{"key":"R19-2-20210129","first-page":"885","article-title":"Expression and significance of microRNAs in the p53 pathway in ovarian cancer cells and serous ovarian cancer tissues (in Chinese)","volume":"33","author":"Zhang","year":"2011","journal-title":"Chin J Oncol"},{"key":"R20-2-20210129","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nature09267","article-title":"Mammalian microRNAs predominantly act to decrease target mRNA levels","volume":"466","author":"Guo","year":"2010","journal-title":"Nature"},{"key":"R21-2-20210129","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrg2936","article-title":"Gene silencing by microRNAs: Contributions of translational repression and mRNA decay","volume":"12","author":"Huntzinger","year":"2011","journal-title":"Nat Rev Genet"},{"key":"R22-2-20210129","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s13277-012-0632-8","article-title":"Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells","volume":"34","author":"Cao","year":"2013","journal-title":"Tumour Biol"},{"key":"R23-2-20210129","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1038\/sj.onc.1205353","article-title":"Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway","volume":"21","author":"Mirza","year":"2002","journal-title":"Oncogene"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/0366-6999.181965","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T07:19:00Z","timestamp":1718522340000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00029330-201605200-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,20]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.4103\/0366-6999.181965","relation":{},"ISSN":["0366-6999"],"issn-type":[{"value":"0366-6999","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5,20]]}}}